Public list: Unicorns - Billion Dollar Startups (261) BIO 2016 (619) Smart Money VCs (6328) Pharma Startups (4733)
Intarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enha...Show all
Company (Alive / Active)
Phone: 617-936-2500
155 Seaport Boulevard
11th Floor
Boston, 02210
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Intarcia Therapeutics | $1513.7M | Apr 3, 2017 |
| ARYX Therapeutics | $132M | Nov 5, 2008 |
| Allon Therapeutics | $2.5M | Sep 10, 2004 |
| See all 96 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline hba1c | Sep 30, 2015 | Feb 13, 2018 | Patent |
| Methods of manufacturing viscous liquid pharmaceutical formulations | Aug 29, 2012 | Aug 08, 2017 | Patent |
| Osmotic delivery device comprising an insulinotropic peptide and uses thereof | Oct 12, 2016 | Jun 20, 2017 | Patent |
| Devices, formulations, and methods for delivery of multiple beneficial agents | Dec 23, 2014 | Feb 21, 2017 | Patent |
| Two-piece, internal-channel osmotic delivery system flow modulator | Feb 26, 2015 | Jan 10, 2017 | Patent |
Download PDF